Barclays’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $537M | Buy |
584,100
+108,200
| +23% | +$110M | 0.13% | 120 |
|
|
2025
Q4 | $511M | Buy |
475,900
+359,900
| +310% | +$344M | 0.12% | 117 |
|
|
2025
Q3 | $88.5M | Sell |
116,000
-46,100
| -28% | -$34.3M | 0.02% | 547 |
|
|
2025
Q2 | $126M | Buy |
162,100
+39,100
| +32% | +$30.4M | 0.03% | 397 |
|
|
2025
Q1 | $102M | Sell |
123,000
-85,800
| -41% | -$71.4M | 0.03% | 413 |
|
|
2024
Q4 | $161M | Buy |
208,800
+7,000
| +3% | +$5.8M | 0.05% | 273 |
|
|
2024
Q3 | $179M | Buy |
+201,800
| New | +$181M | 0.05% | 277 |
|
|
2024
Q2 | – | Sell |
-39,100
| Closed | -$30.4M | – | 5118 |
|
|
2024
Q1 | $30.4M | Sell |
39,100
-6,500
| -14% | -$4.63M | 0.01% | 812 |
|
|
2023
Q4 | $26.6M | Buy |
+45,600
| New | +$26.6M | 0.01% | 938 |
|
|
2023
Q2 | – | Sell |
-116,700
| Closed | -$40.1M | – | 4837 |
|
|
2023
Q1 | $40.1M | Sell |
116,700
-42,800
| -27% | -$14.4M | 0.02% | 561 |
|
|
2022
Q4 | $58.4M | Buy |
+159,500
| New | +$56.6M | 0.03% | 431 |
|
|
2022
Q1 | – | Sell |
-97,100
| Closed | -$26.8M | – | 5328 |
|
|
2021
Q4 | $26.8M | Buy |
97,100
+6,800
| +8% | +$1.72M | 0.01% | 829 |
|
|
2021
Q3 | $20.9M | Buy |
90,300
+36,400
| +68% | +$8.98M | 0.01% | 865 |
|
|
2021
Q2 | $12.4M | Buy |
53,900
+51,800
| +2,467% | +$10.4M | 0.01% | 1110 |
|
|
2021
Q1 | $392K | Sell |
2,100
-196,300
| -99% | -$38.4M | ﹤0.01% | 3327 |
|
|
2020
Q4 | $33.5M | Sell |
198,400
-17,800
| -8% | -$2.66M | 0.02% | 594 |
|
|
2020
Q3 | $32M | Buy |
216,200
+15,500
| +8% | +$2.4M | 0.02% | 549 |
|
|
2020
Q2 | $33M | Buy |
200,700
+24,100
| +14% | +$3.7M | 0.03% | 442 |
|
|
2020
Q1 | $24.5M | Buy |
176,600
+131,700
| +293% | +$18.1M | 0.02% | 558 |
|
|
2019
Q4 | $5.9M | Buy |
44,900
+900
| +2% | +$104K | ﹤0.01% | 1839 |
|
|
2019
Q3 | $4.92M | Sell |
44,000
-110,200
| -71% | -$12.3M | ﹤0.01% | 1868 |
|
|
2019
Q2 | $17.1M | Buy |
154,200
+77,800
| +102% | +$9.16M | 0.01% | 1019 |
|
|
2019
Q1 | $9.91M | Sell |
76,400
-440,300
| -85% | -$53.5M | 0.01% | 1228 |
|
|
2018
Q4 | $59.8M | Sell |
516,700
-29,200
| -5% | -$3.26M | 0.05% | 322 |
|
|
2018
Q3 | $58.6M | Sell |
545,900
-116,800
| -18% | -$11.7M | 0.04% | 355 |
|
|
2018
Q2 | $56.5M | Buy |
662,700
+245,300
| +59% | +$20.1M | 0.05% | 325 |
|
|
2018
Q1 | $32.3M | Buy |
417,400
+282,700
| +210% | +$22.8M | 0.02% | 614 |
|
|
2017
Q4 | $11.4M | Sell |
134,700
-23,400
| -15% | -$1.99M | 0.01% | 1118 |
|
|
2017
Q3 | $13.5M | Sell |
158,100
-32,500
| -17% | -$2.67M | 0.01% | 868 |
|
|
2017
Q2 | $15.7M | Buy |
190,600
+18,100
| +10% | +$1.48M | 0.02% | 716 |
|
|
2017
Q1 | $14.5M | Sell |
172,500
-452,000
| -72% | -$36.2M | 0.02% | 687 |
|
|
2016
Q4 | $45.9M | Sell |
624,500
-1,173,400
| -65% | -$87.4M | 0.05% | 293 |
|
|
2016
Q3 | $144M | Buy |
1,797,900
+1,669,600
| +1,301% | +$134M | 0.16% | 87 |
|
|
2016
Q2 | $10.1M | Buy |
128,300
+31,200
| +32% | +$2.35M | 0.01% | 838 |
|
|
2016
Q1 | $6.99M | Sell |
97,100
-32,600
| -25% | -$2.47M | 0.01% | 952 |
|
|
2015
Q4 | $10.9M | Sell |
129,700
-3,000
| -2% | -$249K | 0.01% | 846 |
|
|
2015
Q3 | $11M | Buy |
132,700
+56,700
| +75% | +$4.79M | 0.01% | 882 |
|
|
2015
Q2 | $6.31M | Sell |
76,000
-108,200
| -59% | -$8.24M | 0.01% | 1320 |
|
|
2015
Q1 | $13.3M | Sell |
184,200
-148,600
| -45% | -$10.6M | 0.02% | 916 |
|
|
2014
Q4 | $22.6M | Buy |
332,800
+160,000
| +93% | +$10.8M | 0.02% | 697 |
|
|
2014
Q3 | $11.1M | Sell |
172,800
-8,200
| -5% | -$519K | 0.01% | 1097 |
|
|
2014
Q2 | $11.2M | Sell |
181,000
-41,500
| -19% | -$2.48M | 0.01% | 1065 |
|
|
2014
Q1 | $12.9M | Sell |
222,500
-148,500
| -40% | -$8.29M | 0.01% | 967 |
|
|
2013
Q4 | $18.9M | Sell |
371,000
-39,800
| -10% | -$1.99M | 0.02% | 794 |
|
|
2013
Q3 | $20.5M | Buy |
410,800
+15,800
| +4% | +$827K | 0.02% | 656 |
|
|
2013
Q2 | $19.4M | Buy |
+395,000
| New | +$21.5M | 0.02% | 658 |
|
Other funds holding LLY
VCM
VPM
Barclays's LLY Position: Q1 2026 in Review
Barclays increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $162M and bringing the position to 1,563,625 shares worth $1.44B. The position accounts for 0.35% of the portfolio, ranked #33.
Barclays first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.87B in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Barclays held 1,563,625 shares of Eli Lilly worth $1.44B as of Q1 2026.
- Barclays bought 159,958 Eli Lilly shares in Q1 2026, an estimated $162M.
- Eli Lilly made up 0.35% of Barclays's portfolio in Q1 2026, its #33 holding.
- Barclays first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Barclays's Eli Lilly position peaked at $1.87B in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.